Dr. Mohammed Orloff, Jeff Owens, and Dr. Nan Sethakorn gave three great presentations in the "Advances in #Biomarkers, #Diagnostics, and #Therapeutics" Session at the 3rd @scheq.org #LungCancer Interventions Summit. #LCSM #SCHEQ #LCIS2025
Dr. Sethakorn from Loyola discussed various ways therapeutics are used to treat #lungcancer at the 3rd @scheq.org Lung Cancer Interventions Summit. #LCSM #LCIS2025 #SCHEQ
Dr. Orloff discussed #earlydetection and #Biomarkers, as well as additional risk factors at the 3rd @scheq.org Lung Cancer Interventions Summit. #LCIS2025 #SCHEQ #LCSM #lungcancer
Drs. Villena-Vargas, Faubert, and Mitchell presented in the "Bench and Translational Research: Barriers and Challenges" session at the 3rd @scheq.org Lung Cancer Interventions Summit. They touched on #IO, #metabolism, #genetics, and #SDOH. #LCIS2025 #SCHEQ
Dr. Mitchell discussed some of her bench to the community #lungcancer research at the 3rd @scheq.org Lung Cancer Intervention Summit. She touched on #SDOH, #epigenetics, #genomics, and disparities. #SCHEQ #LCIS2025
Dr. Faubert gave a very cool talk on tumor #metabolism in #NSCLC and he identified a therapy that while it does not slow tumor growth, it does stop #metastasis. @scheq.org #SCHEQ #LCIS2025
Dr. Villena-Vargas discussed his translational work on tumor draining lymphocytes in #NSCLC at the @scheq.org 3rd Lung Cancer Interventions Summit. #SCHEQ #LCIS2025
Drs. @laurengroner.bsky.social, Trenard, and Carter-Bawa presented frameworks, interventions, and meeting people where they are in the "Innovations in Lung Cancer Screening and Diagnosis: Success Stories" session at @scheq.org #SCHEQ #LCIS2025 #lungcancerscreening #lungcancer
Readouts from some of the lunch #breakouts at the 3rd @scheq.org Lung Cancer Interventions Summit. These included #communityengagement, multi stakeholder partnerships, #medicalracism, use of #socialmedia, #Ruralhealth disparities, and #lungcancerscreening. #SCHEQ #LCIS2025
Dr. Watson gave a great keynote that discussed the pos and cons of the NLST trials and the importance of representation in studies. He also weaved in lived experience , #communityengagebeht, and how data can drive policy decisions at #SCHEQ #LCIS2025
We had a great #Patient Perspectives Panel that was moderated by Angela James. Thanks Ruby, Juanita, Natalie, and Dave for telling your stories. One big takeaway was that each of them had a different life before #lungcancer. #LCIS2025 #SCHEQ @emanleyjr.bsky.social
Jim gave a great summary of the challenges that US Veterans face navigating #lungcancer. One big takeaway is that the decisions on who is "exposed" to carcinogens can change based on location. #LCIS2025 #SCHEQ
Dr. Kennedy gave a great overview of #SCLC and how to help patients navigate trials and treatments when they have transportation challenges. #LCIS2025 #SCHEQ
VK Gadi gave an overview of the work that the University of Illinois Cancer Center is doing and how they include community input into whether clinical trials are conducted. #cancercenter #communityengagement #SCHEQ #LCIS2025
Dr. Carter-Bawa discussed improving #lungcancerscreening through using social media and meeting people where they are. #SCHEQ #LCIS2025
Dr. @laurengroner.bsky.social proposed sobe multi tiered interventions that can be done to increase lung cancer screening. #lungcancerscreening #SCHEQ #LCIS2025
Dr. Watson gave a wide ranging keynote that touched on #lungcancerscreening, redlining, lived experience, advocacy, and community engagement. #SCHEQ #LCIS2025
Kathleen Kennedy gave an overview of #SCLC, new clinical trials, and navigating patients with travel challenges @scheq.org 3rd Lung Cancer Interventions Summit. #SCHEQ #LCIS2025
VK Gadi gave an overview of the work they are doing with underserved communities and how they require their input before #clinicaltrials are adopted. @scheq.org #LCIS2025 #SCHEQ
The Lung Cancer Interventions Summit app has launched. Check it out to see the agenda and speakers.
#lungcancer #lcsm #disparities #innovation #lungcancernodules #lungcancerscreening #clinicaltrials #SCHEQ #LCIS2025
